arrow
K

Kozo Kataoka

Hyogo Medical University
H指数:19
被引数:1,764

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4)

II/III期结直肠癌根治性切除术后时间依赖性复发模式:四项III期随机对照试验的整合分析(JCOG2310A-S4)

2026-07-230
PRE
Efficacy and safety of second-line fluorouracil, leucovorin, and irinotecan plus ramucirumab according to prior first-line regimens in metastatic colorectal cancer: a multicenter retrospective study

二线氟尿嘧啶、亚叶酸钙和伊立替康联合雷莫芦单抗的疗效与安全性:基于既往一线方案在转移性结直肠癌中的多中心回顾性研究

2026-04-220
PRE
Prognostic and Predictive Role of Lymph Node Count in Stage II Colon Cancer: A Retrospective Analysis of a Japanese Nationwide Cohort

淋巴结计数在II期结肠癌中的预后和预测作用:一项基于日本全国队列的回顾性分析

2025-11-010
OAAI
Lecithinized superoxide dismutase prevents oxaliplatin-induced peripheral neuropathy: a double-blind, placebo-controlled, randomized phase II study

卵磷脂化超氧化物歧化酶可预防奥沙利铂诱导的周围神经病变:一项双盲、安慰剂对照、随机II期研究

2025-11-010
OA
Risk of Peritoneal Recurrence Following Laparoscopic Versus Open Surgery for Stage II/III Colorectal Cancer: An Integrated Analysis of Three Phase III Randomized Controlled Trials (JCOG2310AS2)

腹腔镜与开腹手术治疗II/III期结直肠癌后腹膜复发的风险:一项三项III期随机对照试验的整合分析(JCOG2310AS2)

2025-10-260
PRE
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究:一项前瞻性队列研究

2025-09-260
OAAI
Optimal Extent of Lymph Node Dissection for Non-Metastatic Colon Cancer by Tumor Location: Evaluation of the Therapeutic Value Index for Each Lymph Node Station

非转移性结直肠癌淋巴结清扫的最适范围:基于肿瘤位置的各淋巴结站点的治疗价值指数评估

2025-04-210
OAAI
Oral antimicrobial prophylaxis was associated with preventing surgical site infection following 2-stage restorative proctocolectomy in patients with ulcerative colitis

口服抗菌药物预防与溃疡性结肠炎患者行两阶段修复性直肠结肠切除术后的手术部位感染预防相关。

2025-03-230
OA
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)
2025-01-010
PRE
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

2024-09-161
OAAI
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: Subgroup analysis from CIRCULATE-Japan GALAXY

基于分子残留病灶检测的辅助化疗在切除的结直肠癌肝转移中的生存获益:来自CIRCULATE-Japan GALAXY研究的亚组分析

2024-09-011
PRE
EORTC 1409 GITCG/ESSO 01-A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet need
EJSO
IF2.9
2023-11-015
PRE